Loading patent…
AssigneeImmutrix Therapeutics, Inc.
InventorsCarol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
Estimating the term…
A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a third filtrate.
A method comprising:
An extracorporeal system comprising at least three adsorbent materials and a computer system, wherein the adsorbent materials comprise a synthetic carbon particle (SCP), wherein the SCP comprises a bimodal distribution of pores, a first mixture, wherein the first mixture comprises the SCP and an anion resin, wherein the weight ratio of the SCP to the anion exchange resin is in range from about 0.1:100 to about 100:0.1, and a second mixture, wherein the second mixture comprises the SCP and a cation exchange resin, wherein the weight ratio of the SCP to the cation exchange resin is in range from about 0.1:100 to about 100:0.1.
Dependencies are inferred from the claim text.